Vemurafenib for the treatment of melanoma

Author： Jordan Emmet John   Kelly Catherine M  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2533-2543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Abiraterone acetate for the treatment of prostate cancer

By Ryan Charles J   Cheng Michael L  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 91-96

Informa Healthcare

Access to resources Recommend Favorite

Drug safety evaluation of vemurafenib in the treatment of melanoma

By Tsai Kenneth Y   Nowroozi Sasan   Kim Kevin B  

Expert Opinion on Drug Safety, Vol. 12, Iss. 5, 2013-09 ,pp. : 767-775

Informa Healthcare

Access to resources Recommend Favorite

Vemurafenib: Development of resistance during treatment for malignant melanoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1373, 2011-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment

By Zmily Hammam D   Alani Anas   Ghali Jalal K  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 5, 2013-05 ,pp. : 645-655

Informa Healthcare

Access to resources Recommend Favorite

Aromatase inhibitors for female infertility treatment

By Atay Vedat   Yarali Hakan   Bozdag Gurkan   Ozisik Gokhan   Akin Demet   Muhcu Murat  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 2, 2007-02 ,pp. : 137-145

Informa Healthcare

Access to resources Recommend Favorite